Patents by Inventor Barry A. Hendriksen

Barry A. Hendriksen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-methyl-thieno-benzodiazepine formulation
    Patent number: 7303764
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: December 4, 2007
    Assignee: Eli Lilly and Company
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Publication number: 20040097489
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Application
    Filed: July 3, 2003
    Publication date: May 20, 2004
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Patent number: 6617321
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation or olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Grant
    Filed: May 1, 2002
    Date of Patent: September 9, 2003
    Assignee: Eli Lilly and Company
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Publication number: 20030027816
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Application
    Filed: May 1, 2002
    Publication date: February 6, 2003
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • Pesticidal formulation
    Patent number: 4174960
    Abstract: There are described novel pesticidal formulations in concentrate form which are aqueous emulsions containing 10% to 75% by weight of an herbicidal 2,6-dinitroaniline derivative, such as trifluralin, up to 60% by weight of water-immiscible solvent, 0.5% to 10% by weight of an emulsifying agent and 15% to 70% by weight of an aqueous solution of an inorganic salt, such as sodium chloride. The concentration of the inorganic salt in the aqueous solution is at least 5% by weight. The aqueous solution may additionally contain urea. The novel formulations are readily dispersible in large volumes of water in preparation for spraying and present a reduced fire risk compared with conventional concentrated formulations of 2,6-dinitroaniline herbicides.
    Type: Grant
    Filed: February 2, 1978
    Date of Patent: November 20, 1979
    Assignee: Lilly Industries Limited
    Inventor: Barry A. Hendriksen